COMPASS Pathways plc is projected to rise to $21.81 by 2027, a +60% move from its current price of $13.64. CMPS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $13.10 | $13.64 | $14.20 | 0.00% |
| Jul 14 | $12.88 | $13.64 | $14.44 | 0.00% |
| Jul 15 | $12.72 | $13.64 | $14.63 | 0.00% |
| Jul 16 | $12.58 | $13.64 | $14.78 | 0.00% |
| Jul 17 | $12.46 | $13.64 | $14.92 | -0.01% |
| Jul 18 | $12.36 | $13.64 | $15.05 | -0.01% |
| Jul 19 | $12.26 | $13.64 | $15.17 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.26 | $13.64 | $15.17 | -0.01% |
| Week 2 | $11.73 | $13.64 | $15.86 | -0.02% |
| Week 3 | $11.34 | $13.64 | $16.40 | -0.03% |
| Week 4 | $11.02 | $13.64 | $16.87 | -0.03% |
| Week 5 | $10.74 | $13.63 | $17.30 | -0.04% |
| Week 6 | $10.50 | $13.63 | $17.70 | -0.05% |
| Week 7 | $10.28 | $13.63 | $18.07 | -0.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
COMPASS Pathways plc is a biotechnology company focused on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
COMPASS Pathways operates within the Healthcare category, pursuing innovative therapies for mental health conditions. Its work centers on psilocybin-based treatment approaches, with a focus on advancing late-stage clinical development in areas of high unmet need.
COMPASS Pathways plc (CMPS) trades at $13.29 per share and has a market capitalization of $1.79B, ranking 2149 by market cap.
The 2026 forecast shows an average price of $13.29 with a min of $5.22 and a max of $18.09, yielding a 0% ROI and a Neutral sentiment.
Beyond 2026, the forecast projects bullish momentum, with 2027 average $21.72 and 2028 average $24.55, rising to 2029 $28.50 and 2030 $32.16 on average. It further envisions continued upside through 2031 ($33.40 avg), 2032 ($39.07 avg), 2033 ($46.13 avg), and 2034 ($60.35 avg) with progressively higher maxes and ROI. By 2040 the average is $108.26 and by 2050 it is $238.11, with a max forecast of $215.76 in 2040 and $533.99 in 2050, and bullish sentiment persisting through 2050.
Overall, the outlook combines current positioning with a long-run path to substantially higher prices in the forecast horizon, while noting these figures are estimates and not guarantees.
A major floor 61.7% below — a decisive break under it would weaken the trend.
The nearest floor, 19.1% below — buyers have tended to step in here.
The nearest ceiling, 10.5% above — a clean break opens room to run.
A major ceiling 26.7% above — clearing it would confirm fresh momentum.
Key CMPS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CMPS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.41 | Buy | $13.58 | Buy |
| MA 10 | $13.80 | Sell | $13.48 | Buy |
| MA 20 | $13.03 | Buy | $13.11 | Buy |
| MA 50 | $11.79 | Buy | $11.76 | Buy |
| MA 100 | $9.29 | Buy | $10.12 | Buy |
| MA 200 | $7.79 | Buy | $8.43 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.43 | Neutral |
| Stoch RSI (14) | 21.26 | Neutral |
| CCI (20) | 47.95 | Neutral |
| Williams %R (14) | -57.43 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | 7.83 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 42.57 | Neutral |
| TRIX (15) | 0.76 | Buy |
| Awesome (5,34) | 0.69 | Buy |
| Ultimate (7,14,28) | 48.35 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 13.54 | Buy |
| ADX (14) | 19.05 | Neutral |
| ATR (14) | 0.50 | Info |
The 30-day technical picture is bullish. RSI(14) is 60, and the moving averages show the short-term trend with SMA(50) at $11.25 and SMA(200) at $7.53.
Key support and resistance are at $10.07 and $15.07, respectively. The 30-day range spans from a low of $10.02 to a high of $17.64, providing near-term drift within those bounds.
Annualized volatility stands at 80%, indicating elevated price movement potential over the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.22 | $13.64 | $18.32 | 0% | Neutral | |
| $16.60 | $21.81 | $30.74 | +60% | Bullish | |
| $18.30 | $25.11 | $37.24 | +84% | Bullish | |
| $20.06 | $28.55 | $44.05 | +109% | Bullish | |
| $21.78 | $32.03 | $51.07 | +135% | Bullish | |
| $22.74 | $34.47 | $56.54 | +153% | Bullish | |
| $25.53 | $39.80 | $66.96 | +192% | Bullish | |
| $29.72 | $47.60 | $81.93 | +249% | Bullish | |
| $37.89 | $62.26 | $109.43 | +356% | Bullish | |
| $43.15 | $72.69 | $130.25 | +433% | Bullish | |
| $60.05 | $113.67 | $220.64 | +733% | Bullish | |
| $107.34 | $238.54 | $518.96 | +16.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.22 | $13.64 | $16.50 | +0.00% |
| August 2026 | $11.08 | $13.25 | $16.40 | -2.83% |
| September 2026 | $11.27 | $13.62 | $17.13 | +2.79% |
| October 2026 | $11.65 | $14.21 | $18.11 | +4.31% |
| November 2026 | $11.39 | $13.99 | $18.03 | -1.53% |
| December 2026 | $11.37 | $14.08 | $18.32 | +0.59% |
Click any year to see its month-by-month CMPS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CMPS price prediction for 2026 points to an average of $13.64 (low $5.22, high $18.32) — a potential gain of 0% on today's $13.64. Price action looks broadly range-bound.
In 2027, CMPS is projected to trade between $16.60 and $30.74, averaging $21.81 — a potential gain of +60% from today's $13.64. That is up +60% on the projected 2026 average. Buyers look set to stay in control over this stretch.
COMPASS Pathways plc's 2028 outlook centres on $25.11, within a $18.30 to $37.24 range. That is up +15% on the projected 2027 average. That marks a +84% change versus current levels. Momentum favours further upside here.
By 2029, CMPS could reach as high as $44.05, with a base case around $28.55 and support toward $20.06 — roughly +109% from $13.64. Buyers look set to stay in control over this stretch.
Expect CMPS to range from $21.78 to $51.07 through 2030. The $32.03 average target implies a +135% move from current prices. That is up +12% on the projected 2029 average. Momentum favours further upside here.
The CMPS price prediction for 2031 points to an average of $34.47 (low $22.74, high $56.54) — a potential gain of +153% on today's $13.64. Buyers look set to stay in control over this stretch.
In 2032, CMPS is projected to trade between $25.53 and $66.96, averaging $39.80 — a potential gain of +192% from today's $13.64. That is up +15% on the projected 2031 average. Momentum favours further upside here.
COMPASS Pathways plc's 2033 outlook centres on $47.60, within a $29.72 to $81.93 range. That is up +20% on the projected 2032 average. That marks a +249% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, CMPS could reach as high as $109.43, with a base case around $62.26 and support toward $37.89 — roughly +356% from $13.64. Momentum favours further upside here.
Expect CMPS to range from $43.15 to $130.25 through 2035. The $72.69 average target implies a +433% move from current prices. That is up +17% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The CMPS price prediction for 2040 points to an average of $113.67 (low $60.05, high $220.64) — a potential gain of +733% on today's $13.64. Momentum favours further upside here.
In 2050, CMPS is projected to trade between $107.34 and $518.96, averaging $238.54 — a potential gain of +16.5x from today's $13.64. That is up +110% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CMPS today (≈ 73.313783 CMPS) could be worth
$17,488.07
+$16,488.07 (+1649%) by 2050 · US Dollar
Based on the average projected CMPS price of $238.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CMPSwould be worth at today's price.
$1,000 invested in CMPS on Jul 10, 2025 (≈ 268.817202 CMPS) would be worth
$3,666.67
+$2,666.67 (+266.7%) today · 3.67× · US Dollar
Based on a CMPS entry price of $3.72 vs. today's $13.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.62 | $1,001.47 | +0.1% |
| 1 month ago | $11.03 | $1,236.63 | +23.7% |
| 3 months ago | $5.53 | $2,466.55 | +146.7% |
| 6 months ago | $7 | $1,948.57 | +94.9% |
| 1 year ago | $3.72 | $3,666.67 | +266.7% |
| All time (5.0y) ago | $38.62 | $353.18 | -64.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CMPS forecast.
Our base-case forecast reaches $27.00 around 2029.
Implied market cap at $27.00: $3.64B
The multi-year forecast points to meaningful upside, with the 2030 average price at $32.16 and an ROI of 142%, the 2040 average at $108.26 with an ROI of 714.6%, and the 2050 average at $238.11 with an ROI of 1691.6%.
Sentiment in the long horizon is bullish from 2027 onward, aligning with rising average prices toward the end of the forecast period.
These are estimates, not guarantees. They reflect modeled projections and should be considered in the context of market conditions and other uncertainties that could influence actual results.
Tap a question to reveal the answer.
The 2026 forecast shows a min of $5.22, an average of $13.29, and a max of $18.09, with a 0% ROI and Neutral sentiment.
The 2030 forecast shows an average of $32.16 with a min of $21.45 and a max of $52.22, and an ROI of 142; sentiment is Bullish.
Yes. The forecast max reaches $108.49 in 2034, $134.05 in 2035, $215.76 in 2040, and $533.99 in 2050.
$1.79B.
COMPASS Pathways plc Community Discussion
0Share your COMPASS Pathways plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.